4.7 Article

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy

Related references

Note: Only part of the references are listed.
Article Oncology

Post-irradiation endolymphatic hydrops vs. post-irradiation sudden deafness

Chung -Tang Tien et al.

Summary: This study used MR imaging to differentiate between post-irradiation sudden deafness (PISD) and post-irradiation endolymphatic hydrops (PIEH) in long-term nasopharyngeal carcinoma (NPC) survivors with acute sensorineural hearing loss (SNHL). The findings suggest that MR imaging can help identify the specific disorder, as they have different treatment options and hearing outcomes.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy

David M. Baguley et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)

Article Oncology

Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiation Therapy

Suying Lu et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Otorhinolaryngology

Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population

Sze Ling Chan et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)

Article Oncology

Nasopharyngeal carcinoma incidence and mortality in China, 2013

Kuang-Rong Wei et al.

CHINESE JOURNAL OF CANCER (2017)

Review Oncology

Treatment of late sequelae after radiotherapy for head and neck cancer

Primoz Strojan et al.

CANCER TREATMENT REVIEWS (2017)

Article Otorhinolaryngology

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy

Riina Niemensivu et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2016)

Article Oncology

RISK FACTORS FOR HEARING LOSS IN PATIENTS TREATED WITH INTENSITY-MODULATED RADIOTHERAPY FOR HEAD-AND-NECK TUMORS

Charlotte L. Zuur et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)

Article Oncology

Ototoxicity after radiotherapy for head and neck tumors

Niranjan Bhandare et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

Article Otorhinolaryngology

Permanent unilateral hearing loss after radiotherapy for parotid gland tumors

Lisa van der Putten et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2006)

Article Oncology

A prospective study on radiation-induced changes in hearing function

Franziska Herrmann et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)